Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Blood

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V97.7.2173PMID 11264189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions.

  2000cited by this paper
• Detection of vascular endothelial growth factor in AIDS-related primary effusion lymphomas.

  2000cited by this paper
• Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage

  2000cited by this paper
• c-Src Mediates Mitogenic Signals and Associates with Cytoskeletal Proteins upon Vascular Endothelial Growth Factor Stimulation in Kaposi’s Sarcoma Cells1

  2000cited by this paper
• Impaired CTL Recognition of Cells Latently Infected with Kaposi’s Sarcoma-Associated Herpes Virus1

  2000cited by this paper
• Identification of Antigenic Proteins Encoded by Human Herpesvirus 8 and Seroprevalence in the General Population and among Patients with and without Kaposi's Sarcoma

  2000cited by this paper
• High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

  2000cited by this paper
• Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells.

  1999cited by this paper
• Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

  1999cited by this paper
• Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.

  1999cited by this paper
• Cellular Tropism and Viral Interleukin-6 Expression Distinguish Human Herpesvirus 8 Involvement in Kaposi’s Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman’s Disease

  1999cited by this paper
• Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas.

  1999cited by this paper
• AIDS-related malignancies.

  1998cited by this paper
• Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group.

  1998cited by this paper
• AIDS-Related Malignancies.

  1998cited by this paper
• Human Immunodeficiency Virus Tat Modulates the Flk-1/KDR Receptor, Mitogen-Activated Protein Kinases, and Components of Focal Adhesion in Kaposi’s Sarcoma Cells

  1998cited by this paper
• Current perspectives on the molecular pathogenesis of virus-induced cancers in human immunodeficiency virus infection and acquired immunodeficiency syndrome.

  1998cited by this paper
• Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells.

  1998cited by this paper
• Sexual transmission and the natural history of human herpesvirus 8 infection.

  1998cited by this paper
• SEXUAL TRANSMISSION AND THE NATURAL HISTORY OF HUMAN HERPESVIRUS 8 INFECTION

  1998cited by this paper
• Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells.

  1997cited by this paper
• AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.

  1997cited by this paper
• Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.

  1997cited by this paper
• Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6

  1997cited by this paper
• Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV

  1996cited by this paper
• Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma.

  1996cited by this paper

• Virally encoded interleukin-6 (vIL-6) coordinates with human IL-6 to modulate cytokine expression during KSHV infection

  2025influential citation
• Lymphoproliferations in People Living with HIV: Oncogenic Pathways, Diagnostic Challenges, and New Therapeutic Opportunities

  2025cites this paper
• Spatial and Bulk Transcriptomics Reveal Distinct Molecular Signatures in Kaposi Sarcoma with and Without other KSHV-Associated Diseases

  2025cites this paper
• Kaposi’s Sarcoma: A Non-Communicable Outcome Mainly Prompted by Communicable Diseases in Sub-Saharan Africa

  2025cites this paper
• Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines

  2024cites this paper
• The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis

  2024cites this paper
• HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

  2024cites this paper
• Activation of glucocorticoid receptor signaling inhibits KSHV-induced inflammation and tumorigenesis

  2023cites this paper
• KSHV uses viral IL6 to expand infected immunosuppressive macrophages

  2023influential citation
• Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?

  2023cites this paper
• Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages

  2023cites this paper
• Activation of glucocorticoid receptor signaling inhibits KSHV-induced inflammation and tumorigenesis

  2023cites this paper
• The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy

  2022cites this paper
• Oncologic Treatment of HIV-Associated Kaposi Sarcoma 40 Years on.

  2021cites this paper
• Skin and soft tissue infections

  2021cites this paper
• Pathogens and Carcinogenesis: A Review

  2021cites this paper
• HIV-Associated Cancer Biomarkers: A Requirement for Early Diagnosis

  2021cites this paper
• Kaposi's Sarcoma‐associated Herpesvirus—Antiviral Treatment

  2021cites this paper
• Cytokine-Targeted Therapeutics for KSHV-Associated Disease

  2020cites this paper
• Viral interleukin-6 encoded by an oncogenic virus promotes angiogenesis and cellular transformation by enhancing STAT3-mediated epigenetic silencing of caveolin 1

  2020cites this paper
• Herpesviral Latency—Common Themes

  2020cites this paper
• Regulation of Kaposi’s Sarcoma-Associated Herpesvirus Biology by Host Molecular Chaperones

  2020cites this paper
• Interaction of Human Herpesvirus 8 Viral Interleukin-6 with Human Interleukin-6 Receptor Using In Silico Approach: The Potential Role in HHV-8 Pathogenesis

  2020cites this paper
• Kaposi’s Sarcoma-associated Herpesvirus Viral Interleukin 6 Signaling

  2019cites this paper
• Kaposi sarcoma

  2019cites this paper
• Induction of Kaposi’s Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1

  2019cites this paper
• Kaposi’s Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3

  2019cites this paper
• MicroRNAs and non-coding RNAs in virus-infected cells

  2018cites this paper
• Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.

  2018cites this paper
• Role of Pattern Recognition Receptors in KSHV Infection

  2018cites this paper
• Kaposi’s Sarcoma-Associated Herpesvirus-Encoded Viral IL-6 (vIL-6) Enhances Immunoglobulin Class-Switch Recombination

  2018influential citation
• Reactivation and Lytic Replication of Kaposi’s Sarcoma-Associated Herpesvirus: An Update

  2017cites this paper
• Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood

  2017cites this paper
• Omega-3 decreases IL-6 levels in HIV and human herpesvirus-8 coinfected patients in Uganda

  2017cites this paper
• Omega-3 decreases interleukin-6 levels in HIV and HHV-8 co-infected patients : results from a randomized supplementation trial in Uganda

  2017cites this paper
• The Role of Viral Interleukin-6 in Tumor Development of Kaposi's Sarcoma-Associated Herpesvirus Lymphomas

  2016cites this paper
• In vitro models of lymphatic endothelial cells: cytokine receptor expression profiling and incorporation into organotypic culture models

  2016cites this paper
• Bone marrow manifestations in multicentric Castleman disease

  2016cites this paper
• Report on Carcinogens Monograph on Kaposi Sarcoma-Associated Herpesvirus

  2016influential citation
• Gross Hepatosplenomegaly In A Patient With Human Herpes Virus-8 Associated Multicentric Castleman's Disease.

  2016cites this paper
• Eccentric, concentric and isometric strength in trained and untrained older adults

  2015cites this paper
• KSHV‐associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies

  2015cites this paper
• Mimicry of cytokine pathways by human herpesviruses

  2015cites this paper
• Kaposi’s Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration

  2015cites this paper
• Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1

  2015cites this paper
• Etude de l'impact clinique et immunologique d'un traitement par lénalidomide dans la maladie de Kaposi liée au VIH

  2015cites this paper
• HIV and KSHV-Related Cancers: Diseases at the Crossroads of Virology, Immunology, and Cell Biology: Although combination antiretroviral therapy makes AIDS less deadly, HIV-infected individuals remain vulnerable to a variety of cancers

  2015cites this paper
• Peer-Review Draft: Report on Carcinogens Monograph on Kaposi Sarcoma Herpesvirus

  2015influential citation
• Role of Host MicroRNAs in Kaposi’s Sarcoma-Associated Herpesvirus Pathogenesis

  2014cites this paper
• KSHV: pathways to tumorigenesis and persistent infection.

  2014cites this paper
• Modulation of Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Function by Hypoxia-Upregulated Protein 1

  2014cites this paper
• Is Tocilizumab Safe in Kaposi Sarcoma? A Complex Association Among Rheumatoid Arthritis, Psoriasis, and Kaposi Sarcoma

  2014cites this paper
• Kaposi Sarcoma-Associated Herpesvirus (KSHV) or Human Herpesvirus 8 (HHV-8)

  2014cites this paper
• Biomarkers of HIV-associated Cancer

  2014cites this paper
• Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

  2013cites this paper
• AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV

  2013cites this paper
• Impact of Interleukin-6 in Hematological Malignancies

  2013cites this paper
• Human herpesvirus 8-related Castleman disease in the absence of HIV infection.

  2013cites this paper
• Herpes virus 8: Sarcoma de Kaposi, enfermedad de Castleman y linfoma de efusión primario

  2012cites this paper
• Cancer cachexia: mediators, signaling, and metabolic pathways.

  2012cites this paper
• Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis

  2012cites this paper
• Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome

  2012cites this paper
• HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.

  2012cites this paper
• Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.

  2012cites this paper
• Kaposi's Sarcoma-Associated Herpesvirus ORF57 Promotes Escape of Viral and Human Interleukin-6 from MicroRNA-Mediated Suppression

  2011cites this paper
• Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization.

  2011cites this paper
• Viral Interleukin-6: Role in Kaposi's Sarcoma-Associated Herpesvirus–Associated Malignancies

  2011cites this paper
• Kaposi's sarcoma‐associated herpesviral IL‐6 and human IL‐6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation

  2011cites this paper
• High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

  2011cites this paper
• Synchronous Follicular Lymphoma, Kaposi Sarcoma, and Castleman’s Disease in a HIV-Negative Patient With EBV and HHV-8 Coinfection

  2011cites this paper
• An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

  2010cites this paper
• Inflammation in Carcinogenesis

  2010cites this paper
• Classic Kaposi's sarcoma in Han Chinese and useful tools for differential diagnosis.

  2010cites this paper
• Current knowledge of MicroRNAs and noncoding RNAs in virus-infected cells.

  2010cites this paper
• Promoter methylation of the bone morphogenetic protein‐6 gene in association with adult T‐cell leukemia

  2008cites this paper
• Kaposi-Sarcoma-Associated Herpesvirus

  2008cites this paper
• DETECTION OF HHV-8 IN AUTOPSY SAMPLES FROM AIDS PATIENTS

  2007cites this paper
• Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.

  2007cites this paper
• Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia.

  2007cites this paper
• Interactions between HIV-1 Tat and KSHV.

  2007cites this paper
• Interleukin 27 induces differentiation of neural C6-precursor cells into astrocytes.

  2007cites this paper
• Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders

  2006cites this paper
• Acquired immunodeficiency syndrome—related malignancies in the era of highly active antiretroviral therapy

  2006influential citation
• Structural Requirements for gp80 Independence of Human Herpesvirus 8 Interleukin-6 (vIL-6) and Evidence for gp80 Stabilization of gp130 Signaling Complexes Inducedby vIL-6

  2006cites this paper
• AIDS-related lymphoproliferative disease.

  2006cites this paper
• Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma).

  2006cites this paper
• Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis.

  2005cites this paper
• "Null" Phenotype of persistently KSHV-infected B-Lymphocytes

  2005cites this paper
• Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma

  2005cites this paper
• Review in translational hematology AIDS-related lymphoproliferative disease

  2005cites this paper
• AIDS and associated malignancies

  2005cites this paper
• Therapeutic options for human herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus-related disorders

  2004cites this paper
• Kaposi's Sarcoma-associated Herpesvirus-encoded Viral Interleukin-6 Is Secreted and Modified Differently Than Human Interleukin-6

  2004cites this paper
• Neoplastic conditions in the context of HIV-1 infection.

  2004cites this paper
• Regulation of growth signalling and cell cycle by Kaposi's sarcoma‐associated herpesvirus genes

  2004cites this paper
• HIV infection and AIDS Test for mitochondrial function and DNA: potential and pitfalls Related review: Tests for mitochondrial function and DNA: potentials and pitfalls (pp 5–10)

  2003cites this paper
• Detection of human herpesvirus‐8 in peripheral blood mononuclear cells from adult Japanese patients with multicentric Castleman's disease

  2003cites this paper
• Treatment of gammaherpesvirus-related neoplastic disorders in the immunosuppressed host.

  2003cites this paper
• Pathogenesis and manifestations of human herpesvirus-8-associated disorders.

  2003cites this paper
• Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide

  2003cites this paper